Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
niacin hydroxycarboxylic acid receptor 2 small molecule NA drugbank , DGIDB Coronary Arteriosclerosis[MeSHID:D003324]
Hypertriglyceridemia[MeSHID:D015228]
Coronary heart disease[MeSHID:D003327]
Hyperlipidemia[MeSHID:D006949]
Arteriosclerosis[MeSHID:D001161]
Atherosclerosis[MeSHID:D050197]
Myocardial Infarction[MeSHID:D009203]
Avitaminosis[MeSHID:D001361]
Dyslipidemias[MeSHID:D050171]		 9.43 approved,investigational,nutraceutical agonist
niacin hydroxycarboxylic acid receptor 3 small molecule NA drugbank , DGIDB Coronary Arteriosclerosis[MeSHID:D003324]
Hypertriglyceridemia[MeSHID:D015228]
Coronary heart disease[MeSHID:D003327]
Hyperlipidemia[MeSHID:D006949]
Arteriosclerosis[MeSHID:D001161]
Atherosclerosis[MeSHID:D050197]
Myocardial Infarction[MeSHID:D009203]
Avitaminosis[MeSHID:D001361]
Dyslipidemias[MeSHID:D050171]		 9.9 approved,investigational,nutraceutical agonist
niacin nicotinamide n-methyltransferase small molecule NA drugbank , DGIDB Coronary Arteriosclerosis[MeSHID:D003324]
Hypertriglyceridemia[MeSHID:D015228]
Coronary heart disease[MeSHID:D003327]
Hyperlipidemia[MeSHID:D006949]
Arteriosclerosis[MeSHID:D001161]
Atherosclerosis[MeSHID:D050197]
Myocardial Infarction[MeSHID:D009203]
Avitaminosis[MeSHID:D001361]
Dyslipidemias[MeSHID:D050171]		 28.29 approved,investigational,nutraceutical binder
niacin nicotinate-nucleotide pyrophosphorylase [carboxylating] small molecule NA drugbank , DGIDB Coronary Arteriosclerosis[MeSHID:D003324]
Hypertriglyceridemia[MeSHID:D015228]
Coronary heart disease[MeSHID:D003327]
Hyperlipidemia[MeSHID:D006949]
Arteriosclerosis[MeSHID:D001161]
Atherosclerosis[MeSHID:D050197]
Myocardial Infarction[MeSHID:D009203]
Avitaminosis[MeSHID:D001361]
Dyslipidemias[MeSHID:D050171]		 28.29 approved,investigational,nutraceutical binder
click here to return to the previous page